Recursion Pharmaceuticals Inc Clas (RXRX)
Total Costs & Expenses
$598.86M
TTM · Period ending: · USD
RXRX Total Costs & Expenses
Latest reported$598.86Mperiod ending
Latest reported$598.86Mperiod ending
RXRX TTM Total Costs & Expenses ($88.03M → $598.86M)
TTM Total Costs & Expenses
High-resolution chart · PNG
RXRX total costs & expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Total Costs & Expenses (USD) |
|---|---|
| 598,864,000 | |
| 651,556,000 | |
| 722,692,000 | |
| 767,099,000 | |
| 714,158,000 | |
| 633,775,000 | |
| 537,493,000 | |
| 458,768,000 | |
| 443,984,000 | |
| 421,768,000 | |
| 393,936,000 | |
| 359,040,000 | |
| 325,014,000 | |
| 306,127,000 | |
| 285,408,000 | |
| 278,210,000 | |
| 251,486,000 | |
| 221,071,000 | |
| 192,775,000 | |
| 153,447,000 | |
| 127,881,000 | |
| 102,669,000 | |
| 88,028,000 |